| Product Information |
| Synonym(s) |
Compound C, AMPK Inhibitor, BML-275 |
| Chemical Name |
6-[4-[2-(1-Piperidinyl)ethoxy]phenyl]-3-(4-pyridinyl)pyrazolo[1,5-a]pyrimidine |
| Application |
Dorsomorphin is an effective and specific inhibitor of AMPK |
| CAS Number |
866405-64-3 |
| Purity |
≥99.0% |
| Molecular Weight |
399.49 |
| Molecular Formula |
C₂₄H₂₅N₅O |
| SMILES |
C1CCN(CC1)CCOC2=CC=C(C=C2)C3=CN4C(=C(C=N4)C5=CC=NC=C5)N=C3 |
| Target & IC50 |
KDR/VEGFR2: IC50 = 25.1 nM ALK2/BMPR-I: IC50 = 148 nM AMPK kinase: IC50 = 234.6 nM |
| Solubility |
DMSO: 3 mg/mL (7.51 mM) Ethanol: 2 mg/mL (5.01 mM) |
| Preparing Stock Solutions |
| ConcentrationSolventMass |
1 mg |
5 mg |
10 mg |
| 1 mM |
2.5032 ml |
12.5160 ml |
25.0319 ml |
| 5 mM |
0.5006 ml |
2.5032 ml |
5.0064 ml |
| 10 mM |
0.2503 ml |
1.2516 ml |
2.5032 ml |
| 50 mM |
0.0501 ml |
0.2503 ml |
0.5006 ml |
|
| Shipping |
Gel Pack |
| Storage |
Store at -20°C |
| Research Use |
For Research Use Only. Not Intended for Diagnostic Or Therapeutic Use. |